Clin Infect Dis
-
Correction to: The Xpert MTB/RIF Cycle Threshold Value Predicts Mycobacterium
tuberculosis Transmission to Close Contacts in a Brazilian Prospective
Multicenter Cohort.
Clin Infect Dis. 2026 Sep 30:ciag589. doi: 10.1093.
Eur J Clin Microbiol Infect Dis
- LI XJ, Zhang N, Zhang Q, Chen R, et al
HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk
assessment and exploration of mechanisms to preventive considerations.
Eur J Clin Microbiol Infect Dis. 2026 Sep 29. doi: 10.1007/s10096-026-05686.
Int J Tuberc Lung Dis
- BELLAVIA A, Refera TA, Silva DR, Kherabi Y, et al
Results of the FAST-TB end-users' survey align with priority research questions
on new TB treatment regimens.
Int J Tuberc Lung Dis. 2026;30:427-435.
- GOSHU EM, Woldegiorgis AG, Dememew ZG, Gebremedihin ED, et al
Unmasking isoniazid resistance in rifampicin-susceptible TB: a national
multicentre study using Xpert MTB/XDR.
Int J Tuberc Lung Dis. 2026;30:442-447.
- HABIB MA, Efa SS, Afrin K, Islam N, et al
Diabetes prevalence and factors associated with newly detected diabetes in
elderly TB patients.
Int J Tuberc Lung Dis. 2026;30:454-459.
- MGEYI EN, Swai CA, Luge PA, Kavishe I, et al
Improving childhood TB case notification through intensified clinical services.
Int J Tuberc Lung Dis. 2026;30:436-441.
- ZANGPO T, Norbu T, Tenzin P, Nima G, et al
Factors associated with primary rifampicin-resistant/multidrug-resistant TB: a
case-control study.
Int J Tuberc Lung Dis. 2026;30:448-453.
J Infect Dis
- ALKHAFAJI S, Yang E, Lee K, Chang VK, et al
Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3
Confirmatory Trial for the Treatment of Tuberculosis.
J Infect Dis. 2026 Sep 30:jiag431. doi: 10.1093.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016